Amyloid-β triggers the release of neuronal Hexokinase 1 from mitochondria

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Saraiva, Leonardo M ^a   Seixas da Silva, Gisele S ^a   Galina, Antonio ^a   da Silva, Wagner S ^a   Klein, William L ^b   Ferreira, Sérgio T ^a   de Felice, Fernanda G ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN[1-42]; DEOXYGLUCOSE; HEXOKINASE 1; OLIGOMER; AMYLOID BETA PROTEIN; HEXOKINASE; HK1 PROTEIN, HUMAN; ISOENZYME; REACTIVE OXYGEN METABOLITE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; ENERGY METABOLISM; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; UPREGULATION; ANIMAL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; CYTOSOL; ENZYMOLOGY; HUMAN; METABOLISM; MITOCHONDRION; NERVE CELL; PHYSIOLOGY;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL SURVIVAL; CYTOSOL; DEOXYGLUCOSE; HEXOKINASE; HUMANS; ISOENZYMES; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 78650719636     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015230     Document Type: Article

References (52)

1. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V (2004) In self-defense: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem J 377: 347-355.
2. Huang TJ, Verkhratsky A, Fernyhough P (2005) Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3- kinase in adult sensory neurons. Mol Cell Neurosci 28: 42-54.
3. Gimenez-Cassina A, Lim F, Cerrato T, Palomo GM, Diaz-Nido J (2009) Mitochondrial hexokinase II promotes neuronal survival and acts downstream of glycogen synthase kinase-3. J Biol Chem 284: 3001-3011.
4. Wilson JE (2003) Isozmes of mammalian hexokinase: structure, subcelular localization and metabolic function. J Exp Biol 206: 2049-2057.
5. Rose IA, Warms JV (1967) Mitochondrial hexokinase. Release, rebinding, and location. J Biol Chem 242: 1635-1645.
6. Wang Z, Gardiner NJ, Fernyhough P (2008) Blockade of hexokinase activity and binding to mitochondria inhibits neurite outgrowth in cultured adult rat sensory neurons. Neurosci Lett 434: 6-11.
7. Dringen R (2000) Metabolism and functions of glutathione in brain. Prog Neurobiol 62: 649-671.
8. da-Silva WS, Gomez-Puyou A, De Gomez-Puyou MT, Moreno-Sanchez R, De Felice FG, et al. (2004) Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive species generation in mitochondria. J Biol Chem 279: 39846-55.
9. Vyssokikh MY, Brdiczka D (2003) The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim Pol 50: 389-404.
10. Rothman DL, Behar KL, Hyder F (2004) Trends Neurosci 27: 489-495.
11. Serrano F, Klann E (2004) Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res Rev 3: 431-443.
12. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430: 631-639.
13. Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, et al. (2006) Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimers Dis 9: 147-153.
14. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, et al. (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-Daspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282: 11590-601.
15. Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, et al. (2008) Amyloid-b peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in neurons. J Neurochem 106: 45-55.
16. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
17. Klein WL, Stine WB, Jr., Teplow DB (2004) Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging 25: 569-580.
18. Ferreira ST, Vieira MN, De Felice FG (2007) Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59: 332-345.
19. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
20. Martins SM, Frosoni DJ, Martinez AM, De Felice FG, Ferreira ST (2006) Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231). J Biol Chem 281: 26121-26128.
21. De Felice FG, Houzel JC, Garcia-Abreu J, Louzada PR, Jr., Afonso RC, et al. (2001) Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy. FASEB J 15: 1297-9.
22. De Felice FG, Vieira MN, Saraiva LM, Figueroa-Villar JD, Garcia-Abreu J, et al. (2004) Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J 12: 1366-72.
23. Paula-Lima AC, De Felice FG, Brito-Moreira J, Ferreira ST (2005) Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of betaamyloid in rat hippocampal and cortical neurons. Neuropharmacology 49: 1140-1148.
24. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, et al. (2008) Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A-beta oligomers. Neurobiol Aging 29: 1334-47.
25. De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, et al. (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A 106: 1971-6.
26. Vieira MN, Forny-Germano L, Saraiva LM, Sebollela A, Martinez AM, et al. (2007) Soluble oligomers from a non-disease related protein mimic Abetainduced tau hyperphosphorylation and neurodegeneration. J Neurochem 103: 736-748.
27. Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image Processing with ImageJ. Biophotonics International 11: 36-42.
28. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60: 748-766.
29. Skaff DA, Kim CS, Tsai HJ, Honzatko RB, Fromm HJ (2005) Glucose 6- phosphate release of wild-type and mutant human brain hexokinases from mitochondria. J Biol Chem 280: 38403-38409.
30. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, et al. (2004) Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 16: 819-830.
31. Lorenzo A, Yankner BA (1994) Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 91: 12243-12247.
32. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, et al. (2003) Alzheimer's disease-affected brain: presence of oligomeric Ab ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100: 10417-10422.
33. Piccini A, Russo C, Gliozzi A, Relini A, Vitali A, et al. (2005) Beta-amyloid is different in normal aging and in Alzheimer disease. J Biol Chem 280: 34186-34192.
34. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95: 6448-6453.
35. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal longterm potentiation in vivo. Nature 6880: 535-539.
36. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, et al. (2005) Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25: 7709-7717.
37. Bigl M, Apelt J, Eschrich K, Schliebs R (2003) Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology. J Neural Transm 110: 77-94.
38. Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, et al. (2004) Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice. J Neuropathol Exp Neurol 63: 418-428.
39. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB (2001) Growth factors can influence cell growth and survival through effects on glucose metabolism. Mo Cell Biol 21: 5899-5912.
40. Pellerin L (2005) How astrocytes feed hungry neurons. Mol Neurobiol 32: 59-72.
41. Jolivet R, Magistretti PJ, Weber B (2009) Deciphering neuron-glia compartmentalization in cortical energy metabolism. Front Neuroenergetics 1: 4.
42. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304: 448-452.
43. Andersson CX, Fernandez-Rodriguez J, Laos S, Baeckstrom D, Haass C, Hansson GC (2004) Shedding and gamma-Secretase mediated intramembrane proteolysis of the mucin-type molecule CD43. Biochem J 387: 377-384.
44. Inestrosa NC, Toledo EM (2008) The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease. Mol Neurodegener 24: 3-9.
45. Magdesian MH, Carvalho MM, Mendes FA, Saraiva LM, Juliano MA, et al. (2008) Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem 283: 9359-9368.
46. Baum L, Hansen L, Masliah E, Saitoh T (1996) Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Mol Chem Neuropathol 29: 253-261.
47. Pastorino GJ, Hoek JB, Shulga N (2005) Activation of glycogen synthase kinase 3b disrupts the binding of hkII to mitochondria by phosphorylating voltagedependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 65: 10545-10554.
48. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) Beta- Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376-389.
49. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997) Amyloid betapeptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 17: 1046-1054.
50. Moreira PI, Smith MA, Zhu X, Nunomura A, Castellani RJ, Perry G (2005) Oxidative stress and neurodegeneration. Ann N Y Acad Sci 1043: 545-552.
51. Ly CV, Verstreken P (2006) Mitochondria at the synapse. Neuroscientist 12: 291-299.
52. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16: 1738-1748.